Webinar: Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS
Webinar
Effective Gadolinium Reduction with the New High-Relaxivity Gadopiclenol in CNS
15 January 2025
6:00-7:00 pm CET
The faculty is composed by four renowned neuroradiologists
Andrea Rossi – Gaslini Hospital, Genoa, Italy
Simonetta Gerevini – Papa Giovanni XXIII Hospital, Bergamo, Italy
Martin Wiesmann – University Hospital RWTH Aachen, Aachen, Germany
Josef Vymazal – Na Homolce Hospital, Prague, Czech Republic
Who will be interviewed by the Global Senior Medical Expert of Bracco Gunter Erb.
The purpose of the webinar
The purpose of the webinar is to take the audience on a journey in CNS MRI, where the speakers will share their knowledge and their clinical experience in diagnosing various neuro-pathologies using the new high-relaxivity contrast agent Gadopiclenol.
The benefits of high-relaxivity contrast agents (CAs) and of dose reduction in neuroimaging will be highlighted.
Evidence on how high-relaxivity CAs improve CNS lesion detection and facilitate diagnosis will be provided: the speakers will showcase different neuro-pathologies, such as small metastases, high-grade gliomas, demyelinating diseases- e.g multiple sclerosis- and bone metastases, and how the diagnostic can profit from the use of Gadopiclenol. A special focus on pediatric patients will also be addressed.
The webinar will also feature a live Q&A session, offering you the chance to engage directly with the experts. The webinar will be held in English.
Looking forward to see you on January 15.